This brand name is authorized in Nigeria.
The drug LOXAGYL contains one active pharmaceutical ingredient (API):
1
|
UNII
140QMO216E - METRONIDAZOLE
|
|
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-0283 | Tablet | LOXAGYL 200 TABLET TAB 200 mg 1010 | 6/5/2024 13:42:19 LOXAGYL 200 TABLET METRONIDAZOLE 04-0283 TABLET ORAL METRONIDAZOLE 200MG 1010 POM MAY & BAKER NIGERIA PLC 1 May & Baker Avenue Off Idiroko road Ota Ogun State May & Baker Nigeria Plc 1 May & Baker Avenue Off Idiroko road Ota Ogun State Nigeria 27/01/2022 26/01/2027 Yes A01AB17 | 27/01/2022 |
| 04-0292 | Suspension | Loxagyl Metronidazole Suspension SUSP 200 mg/5 mL 1 x 60 mL | Suspension | 28/01/2021 |
| 04-5566 | Tablet | Loxagyl 400 Tablet+++ TAB 400 mg 10 x 10's (in PVC blisters strip) | Tablet 6/5/2024 12:42:10 LOXAGYL 400 TABLET METRONIDADOLE 04-5566 TABLET ORAL Metronidazole 400mg 1010 OTC May & Baker Nigeria Plc 1 May & Baker Avenue off Idiroko road Ota Ogun state May & Baker Nigeria Plc 1 May & Baker Avenue off Idiroko road Ota Ogun state Nigeria 10/11/2020 09/11/2025 Yes A01AB17 | 10/11/2020 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A01AB17 | Metronidazole | A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AB Antiinfectives and antiseptics for local oral treatment |
| J01XD01 | Metronidazole | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | 04-0283, 04-0292, 04-5566 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.